Long Term Suppressive Therapy With Pegylated Interferon for Chronic Hepatitis C Associated Membranoproliferative Glomerulonephritis

Gut - United Kingdom
doi 10.1136/gut.2006.094508
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C Associated With Thyroid Dysfunction

Acta Hepatologica Japonica
Hepatology
2013English

Acute Pancreatitis Associated With Pegylated Interferon-Alpha-2a Therapy in Chronic Hepatitis C

Clinical and molecular hepatology
MedicineHepatologyMolecular Biology
2016English

Pegylated-Interferon Alpha Therapy for Treatment-Experienced Chronic Hepatitis B Patients

PLoS ONE
Multidisciplinary
2015English

Hepatitis C Eradication and Improvement of Cryoglobulinemia-Associated Rash and Membranoproliferative Glomerulonephritis With Interferon and Ribavirin After Kidney Transplantation

Canadian Journal of Gastroenterology
2006English

Favorable Prognosis of Chronic Hepatitis C After Interferon Therapy by Long-Term Cohort Study

Hepatology
MedicineHepatology
2003English

Comparison of Adverse Effects Related to Pegylated Interferon-Based Therapy for Patients With Chronic Hepatitis B and Chronic Hepatitis C in Taiwan

Hepatology International
Hepatology
2010English

A Long-Term Prognosis After Interferon Therapy for Chronic Hepatiti C.

Acta Hepatologica Japonica
Hepatology
1996English

Sudden-Onset Sarcoidosis With Severe Dyspnea Developing During Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C

Turkish Journal of Gastroenterology
Gastroenterology
2017English

Daclatasvir/Asunaprevir Based Direct-Acting Antiviral Therapy Ameliorate Hepatitis C Virus-Associated Cryoglobulinemic Membranoproliferative Glomerulonephritis: A Case Report

BMC Nephrology
Nephrology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy